Navigation Links
Simbionix USA Corporation's Innovative Development Division Releases Two New Breakthrough Technologies
Date:9/21/2009

CLEVELAND, Ohio, September 21 /PRNewswire/ -- Simbionix USA Corporation, the world's leading developer of medical simulation systems, just released two new products: a new Laparoscopic Essential Tasks Module for its LAP Mentor(TM) and a breakthrough technology for patient-specific simulation based on actual patient data - the PROcedure Rehearsal Studio(TM).

The new Laparoscopic Essential Tasks Module is an addition to the LAP Mentor's ever-expanding library of modules. This new module takes hands-on skill training another step forward, enabling the trainee to practice three essential tasks, similar to the Fundamentals of Laparoscopic Surgery Program (FLS) developed by SAGES.

"The module is a breakthrough technology that provides an efficient and exciting virtual reality environment," explains Simbionix President Ran Bronstein.

During the same week, Simbionix released a new, enhanced version of the PROcedure Rehearsal Studio(TM), marking another important advance in its innovative simulation technology.

This unique product, previously introduced by Simbionix last year, is the world's first medical simulator to enable clinicians to create practice scenarios based on their patient's unique anatomy as reconstructed from CT data.

Inbal Mazor, Simbionix Vice President of Corporate Marketing, adds:"This week's release of the PROcedure Rehearsal Studio with the PACS-enabled capability allows for a wide range of scans and enables the sharing of training cases for educational use. With this new version, the system is now more efficient, easier to use and extremely reliable. We are extremely proud of this new product, which will undoubtedly benefit both patient and clinicians."

Simbionix will present these new releases at upcoming US medical tradeshows this fall: The PROcedure Rehearsal Studio on September 23rd at TCT 2009 in San Francisco and the new Laparoscopic Essential Tasks on Oct 12th at the ACS 2009 annual meeting.

About Simbionix USA Corporation

Simbionix is the leader in the development and delivery of innovative and effective virtual reality simulation products and solutions for clinical education and training of medical professionals. The products are designed to accelerate best-practice medical training, advance clinical performance, and improve patient safety.

The Simbionix product line includes the ANGIO Mentor(TM) line for endovascular procedures, LAP Mentor(TM) line for laparoscopic surgical procedures, GI Mentor(TM) for upper and lower gastrointestinal procedures and the URO Mentor(TM) for urological procedures. In addition, Simbionix distributes the HystSim(TM) for hysteroscopic procedures. Each simulation platform is a leading simulator in the relevant clinical area.

Simbionix simulation products have been validated in several scientific studies and the company cooperates closely with both industry and leading medical institutions to develop the most advanced simulators for the training and assessment of medical professionals.

   http://www.simbionix.com

    Contact:

    Galia Zilbershtein-Salant
    Exhibition Manager
    Simbionix
    Tel : +1-216-229-2040
    galia@simbionix.com



'/>"/>
SOURCE Simbionix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
2. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
3. Simbionix Increases Product Offerings for OB/GYN Physicians
4. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
5. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
6. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
7. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
8. Simbionix Launches Innovative Patient-Specific Simulation
9. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
10. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
11. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... BALTIMORE, Md. (PRWEB) , ... October 11, 2017 ... ... for digital pathology, announced today it will be hosting a Webinar titled, “Pathology ... of  Advanced Pathology Associates , on digital pathology adoption best practices and how ...
(Date:10/11/2017)... ... 11, 2017 , ... A new study published in Fertility ... fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort ... After comparing the results from the fresh and frozen transfer cohorts, the authors ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program ... in Volunteer Experience from US2020. , US2020’s mission is to change the trajectory ...
(Date:10/10/2017)... BARBARA, CALIFORNIA (PRWEB) , ... October 10, 2017 ... ... management, technological innovation and business process optimization firm for the life sciences and ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation ...
Breaking Biology Technology:
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):